For Sales: 888.816.4721 | Contact Us

WorldCare Clinical Continues to Expand Operations to Support Global Trial Imaging

April 02, 2015

Leading Imaging Company Opens New Operations Facility in San Francisco Bay Area

Boston, MA, and Newark, CA, April 2, 2015 – WorldCare Clinical (WCC), a leading provider of imaging services to the pharmaceutical and biotechnology industry, today announced that it has opened a new office in the San Francisco Bay Area. The office expands WorldCare Clinical’s operational reach to a region which is home to hundreds of biotechnology companies and a pool of talented people experienced in clinical trials.

"As a customer-focused imaging CRO, our team’s priority is to deliver the highest quality data and service to sponsors," stated Aaron Timm, CEO of WCC. "As a global provider of imaging services, WorldCare’s presence in this dynamic and innovative region helps us to continue to deliver exceptional service by attracting experienced personnel to effectively support the design and execution of imaging services in clinical trials."

WorldCare Clinical’s office is located at 39899 Balentine Drive, Suite 200, Newark, California, 94560.

About WorldCare Clinical

WorldCare Clinical is a global imaging CRO that employs scientific expertise, innovative technology, and operational excellence to maximize the precision and accuracy of a blinded independent central review of Phase I – IV clinical trial data. The company has worked with thousands of sites in more than 60 countries. WCC’s robust technology platform processes over 250 million images annually (CT, MRI, X-Ray, Echo, US, PET). Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WorldCare continues to maintain a strategic relationship with the Harvard Hospital System as well as other leading academic institutions.

For more information on WCC's services, please visit our website at wcclinical.com or contact:

Thomas O'Donnell


(513) 924-5183